You are currently viewing a new version of our website. To view the old version click .

Vaccines to Reduce Antimicrobial Resistance to Bacterial Pathogens

This special issue belongs to the section “Pathogens-Host Immune Boundaries“.

Special Issue Information

Dear Colleagues,

The rise of antimicrobial resistance has led to the inefficacy of drugs and persistent infections, which consequently increase the risk of severe illness and the spread of disease. To combat antimicrobial resistance, an integrated approach that includes vaccines and antibiotics is needed. Vaccines play a crucial role in preventing infections caused by resistant bacteria, thereby reducing the reliance on antibiotics and slowing the spread of resistance.

This Special Issue aims to provide an overview of advancements in the development of bacterial vaccines targeting antimicrobial-resistant pathogens. The scope of this Special Issue includes the following topics: (i) novel technologies and approaches to the production of bacteria vaccines, (ii) vaccination-induced immune responses, (iii) mucosal vaccines and vaccination, and (iv) the use of vaccines as tools for combating antimicrobial resistance. We welcome the submission of research papers, short communications, and reviews related to these topics.

Dr. Miriam Moscoso
Dr. Astrid Pérez
Dr. Eva Gato
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antimicrobial resistance
  • immune responses
  • infectious diseases
  • bacterial vaccines
  • antibody response
  • cellular response
  • mucosal immunity
  • efficacy evaluation
  • vaccine development

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X